Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM
Clinical trial NCT05159882 · UNKNOWN
Trial details
- NCT number
- NCT05159882
- Sponsor
- Newsoara Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-15
- Primary completion
- 2022-09-30
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.